Arrhythmias in myocardial infarction.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D001285:Atropine / Q000627:therapeutic use; D001919:Bradycardia / Q000209:etiology; D005117:Cardiac Complexes, Premature / Q000188:drug therapy / Q000209:etiology; D003645:Death, Sudden; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004554:Electric Countershock; D006327:Heart Block / Q000209:etiology / Q000628:therapy; D006352:Heart Ventricles; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications* / Q000401:mortality; D010138:Pacemaker, Artificial; D011433:Propranolol / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000628:therapy
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D001285:Atropine; D008012:Lidocaine; D011433:Propranolol; D007545:Isoproterenol